Compliance, infrastructure, and operating wisdom for medical wellness businesses — from the physicians and operators who do this every day.
Florida SB 1728 / HB 1429 would require many med spas that purchase, store, compound, or administer prescription drugs to obtain a Board of Pharmacy license and designate a Responsible Person. Still pending as of March 2026.
Massachusetts H 5087 would sort med spas into three licensing tiers based on procedure risk — with different director and physical-presence requirements at each level. Still pending in the Joint Committee on Public Health.
New York's LLC Transparency Act now requires med spas, MSOs, and holding companies formed as LLCs to disclose beneficial ownership — or file an exemption — with the state. Here's what to do before the January 1, 2027 deadline.
Massachusetts has made it clear — a medical environment does not expand an aesthetician's scope of practice, even with a physician on-site. Here's what med spa operators need to do now.
GLP-1 medications like semaglutide and tirzepatide require a precise legal structure — physician oversight, proper entity setup, legal delegation, and compliant sourcing. Here's how to build a GLP-1 program that holds up.
Oversight and direction sound interchangeable — they aren't. Here's how the two roles differ in scope, liability, and what your clinic actually needs.